SCHEMBL29646565

SCHEMBL29646565

CC(C)(C)OC(=O)N1CCN(CCCCN)C(=O)C1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.39
TP53 P04637 1/20 0.37
ESR2 Q92731 1/20 0.37
USP2 O75604 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ADORA1 P30542 2/20 0.37
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
TPSAB1 Q15661 2/20 0.36
TPSD1 Q9BZJ3 2/20 0.36
TPSG1 Q9NRR2 2/20 0.36
GPR119 Q8TDV5 1/20 0.35
POLB P06746 1/20 0.35
DTYMK P23919 1/20 0.35
CNR2 P34972 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7982635 0.96 NR1H2 (0.40) NR1H2TP53ESR2USP2SMN1; SMN2
SCHEMBL4390630 0.91 NR1H2 (0.41) NR1H2TP53ESR2USP2SMN1; SMN2
SCHEMBL7587617 0.87 PLA2G2A (0.44) NR1H2ESR2USP2SMN1; SMN2ADORA1
SCHEMBL24072420 0.87 PLA2G2A (0.44) NR1H2ESR2USP2SMN1; SMN2ADORA1
SCHEMBL1583540 0.86 CNR2 (0.40) NR1H2ESR2USP2SMN1; SMN2ADORA1
SCHEMBL22692273 0.86 NR1H2 (0.38) NR1H2ESR2USP2SMN1; SMN2ALDH1A1
SCHEMBL18205300 0.85 NR1H2 (0.39) NR1H2TP53ESR2USP2SMN1; SMN2
SCHEMBL1176507 0.85 NR1H2 (0.40) NR1H2TP53ESR2USP2SMN1; SMN2
SCHEMBL12523828 0.84 P2RX7 (0.43) NR1H2TP53ESR2USP2SMN1; SMN2
SCHEMBL21520542 0.84 DDB1 (0.39) NR1H2TP53ESR2USP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4000623-A1 5-(2-(1H-INDOL-3-YL))-ETHYL)- PIPERAZIN-2-ONE DERIVATIVES FOR USE IN THE TREATMENT OF VIRAL INFECTIONS BY VIRUSES OF THE FAMILY CORONAVIRIDAE Consejo Superior De Investigaciones Científicas (ES) 2022-05-25 EP disclosed